Clinical trial to test potential new therapy for giant cell arteritis
An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis (GCA). The study is sponsored ...
Sep 27, 2019
0
2